Pieris Pharmaceuticals, Inc. ( PIRS) - Stock Earnings
Stock symbol PIRS is outdated, potentially delisted? Maybe it is available on other exchange?
PIRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -4.9 million USD | 53000 USD |
| 2024Q2 | -3.6 million USD | — USD |
| 2024Q3 | -2.9 million USD | — USD |
PIRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -43.4 million USD | 31.4 million USD |
| 2022 | -31.3 million USD | 25.9 million USD |
| 2023 | -24.5 million USD | 42.8 million USD |
PIRS
Price: $13.60
52 week price:
Earnings Per Share: -12.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 522800
Ebitda: -5.1 millionMarket Capitalization: 21.9 million